InvestorsHub Logo

fsulevine

06/28/18 11:23 PM

#3272 RE: FredKerx #3271

You are overlooking the fact that the shares of Akebia are much higher. So we are getting the potential of their drug and hopefully much less in overall costs. I think it is good overall.